Geneyx Analysis: Our Most Significant Updates to Date
New Geneyx Analysis Features:
We are excited to announce the latest enhancements to the Geneyx Analysis platform, specifically focused on supporting the ACMG guidelines for CNV/SVs. These updates significantly improve the interpretation and reporting of constitutional copy number variants (CNVs), aligning with the joint consensus recommendations of the ACMG (American College of Medical Genetics and Genomics) and ClinGen (Clinical Genome Resource). For more details on these guidelines here.
Automated ACMG Guideline Calculations:
The CNV/SV tab now automatically calculates ACMG guidelines for all deletion and duplication events. This automation ensures that the technical standards are consistently applied, reducing manual effort and minimizing the risk of human error. Users can quickly obtain standardized interpretations, enhancing the accuracy and reliability of their genomic analyses.
Customizable Interface for Internal Evidence:
Understanding that each laboratory may have unique internal evidence and criteria, we have designed an interface that allows for the modification of ACMG criteria. This flexibility enables you to incorporate their internal data and expertise into the analysis, ensuring that the results are tailored to your individual needs and context. The interface is user-friendly and intuitive, making it easy for you to adjust criteria and see the immediate impact on their CNV interpretations.
Transparency and Audit Trails:
One of the key features of the new interface is its transparency. Similar to the ClinGen CNV calculator, the Geneyx Analysis platform clearly displays all activated or inactivated criteria. Users can see which guidelines have been applied and understand how each decision was made. This transparency is crucial for you in the analysis process and for facilitating reviews and audits.
In addition to transparency, the platform includes comprehensive audit trails for all actions implemented. Every modification and decision is recorded, providing a detailed history of the analysis process. This auditability is essential for regulatory compliance and for maintaining the highest standards of data integrity.
Improved CNV Interpretation and Workflow Automation:
These enhancements to the CNV/SV tab drastically improve CNV interpretation times. By automating guideline calculations and providing a streamlined interface for criteria modification, the platform reduces the time required for each analysis. This efficiency allows you to process more samples in less time, increasing throughput and productivity.
Furthermore, the new features aid in workflow automation, integrating seamlessly with existing laboratory processes. The combination of automated guidelines, customizable criteria, and detailed audit trails supports a more efficient and reliable workflow, freeing up valuable time for researchers and clinicians to focus on more complex tasks and analyses.
In Conclusion:
The new Geneyx Analysis features represent a significant advancement in CNV/SV interpretation and reporting. By supporting ACMG guidelines, providing a customizable and transparent interface, and enhancing workflow automation, the platform empowers you to achieve more accurate, efficient, and reliable genomic analyses. These updates reflect our commitment to continuous improvement and to providing all of our users with the most advanced tools available in genomic analysis.
